Invivyd Stock EBITDA
| IVVD Stock | USD 0.59 0.08 11.94% |
Invivyd fundamentals help investors to digest information that contributes to Invivyd's financial success or failures. It also enables traders to predict the movement of Invivyd Stock. The fundamental analysis module provides a way to measure Invivyd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Invivyd stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -196.6 M | -206.4 M |
Invivyd | EBITDA |
Invivyd Company EBITDA Analysis
Invivyd's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Invivyd EBITDA | (196.62 M) |
Most of Invivyd's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Invivyd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Invivyd EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Invivyd is extremely important. It helps to project a fair market value of Invivyd Stock properly, considering its historical fundamentals such as EBITDA. Since Invivyd's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Invivyd's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Invivyd's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Invivyd Ebitda
Ebitda |
|
According to the company disclosure, Invivyd reported earnings before interest,tax, depreciation and amortization of (196.62 Million). This is 122.41% lower than that of the Biotechnology sector and 296.31% lower than that of the Health Care industry. The ebitda for all United States stocks is 105.04% higher than that of the company.
Invivyd EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Invivyd's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Invivyd could also be used in its relative valuation, which is a method of valuing Invivyd by comparing valuation metrics of similar companies.Invivyd is currently under evaluation in ebitda category among its peers.
Invivyd Institutional Holders
Institutional Holdings refers to the ownership stake in Invivyd that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Invivyd's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Invivyd's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.6 M | Millennium Management Llc | 2024-06-30 | 1.1 M | State Street Corp | 2024-06-30 | 982.7 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 786.9 K | Deutsche Bank Ag | 2024-06-30 | 646.9 K | Citadel Advisors Llc | 2024-09-30 | 625 K | Duquesne Family Office Llc | 2024-09-30 | 571.4 K | Northern Trust Corp | 2024-09-30 | 568.4 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 547.3 K | Maverick Capital Ltd | 2024-09-30 | 11.8 M | Deep Track Capital, Lp | 2024-09-30 | 11 M |
Invivyd Fundamentals
| Return On Equity | -0.97 | ||||
| Return On Asset | -0.54 | ||||
| Operating Margin | (21.75) % | ||||
| Current Valuation | (34.66 M) | ||||
| Shares Outstanding | 119.62 M | ||||
| Shares Owned By Insiders | 18.16 % | ||||
| Shares Owned By Institutions | 79.24 % | ||||
| Number Of Shares Shorted | 8.27 M | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 31.17 X | ||||
| EBITDA | (196.62 M) | ||||
| Net Income | (198.64 M) | ||||
| Cash And Equivalents | 418.67 M | ||||
| Cash Per Share | 3.84 X | ||||
| Total Debt | 2.17 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.14 X | ||||
| Book Value Per Share | 1.61 X | ||||
| Cash Flow From Operations | (173.16 M) | ||||
| Short Ratio | 23.71 X | ||||
| Earnings Per Share | (1.95) X | ||||
| Target Price | 6.51 | ||||
| Number Of Employees | 94 | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 70.57 M | ||||
| Total Asset | 229.18 M | ||||
| Retained Earnings | (732.07 M) | ||||
| Working Capital | 174.59 M | ||||
| Net Asset | 229.18 M |
About Invivyd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Invivyd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invivyd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invivyd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Invivyd is a strong investment it is important to analyze Invivyd's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Invivyd's future performance. For an informed investment choice regarding Invivyd Stock, refer to the following important reports:Check out Invivyd Piotroski F Score and Invivyd Altman Z Score analysis. For information on how to trade Invivyd Stock refer to our How to Trade Invivyd Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invivyd. If investors know Invivyd will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invivyd listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.95) | Revenue Per Share 0.02 | Return On Assets (0.54) | Return On Equity (0.97) |
The market value of Invivyd is measured differently than its book value, which is the value of Invivyd that is recorded on the company's balance sheet. Investors also form their own opinion of Invivyd's value that differs from its market value or its book value, called intrinsic value, which is Invivyd's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invivyd's market value can be influenced by many factors that don't directly affect Invivyd's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invivyd's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invivyd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invivyd's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.